Long-Term Assets: The sum of all assets classified as non-current.
Rocket Pharmaceuticals, Inc. (RCKT) had Long-Term Assets of $143.82M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-68.92M |
|
-- |
|
-- |
|
$71.15M |
|
$-71.15M |
|
$2.23M |
|
$-68.92M |
|
$-68.92M |
|
$-68.92M |
|
$-68.92M |
|
$-68.92M |
|
$-68.92M |
|
$-71.15M |
|
$-68.57M |
|
111.02M |
|
111.02M |
|
$-0.62 |
|
$-0.62 |
|
| Balance Sheet Financials | |
$277.15M |
|
$32.52M |
|
|
Long-Term Assets |
$143.82M |
$420.98M |
|
$43.40M |
|
$19.38M |
|
$23.37M |
|
$66.77M |
|
$354.21M |
|
$289.91M |
|
$354.21M |
|
107.88M |
|
| Cash Flow Statement Financials | |
$-104.75M |
|
$-26.27M |
|
$0.21M |
|
$165.00M |
|
$34.18M |
|
$-130.81M |
|
$21.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.39 |
|
-- |
|
-- |
|
0.05 |
|
0.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-105.17M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.46% |
|
-23.77% |
|
-16.37% |
|
-18.45% |
|
$3.28 |
|
$-0.95 |
|
$-0.94 |
|